Measurable residual disease for secondary acute myeloid leukemia prior to allogeneic hematopoietic cell
Firas El Chaer1, Karen K Ballen2
1Division of Hematology/Oncology, University of Virginia School of Medicine, Charlottesville, VA, USA.
Bone Marrow Transplantation
|July 28, 2022
Abstract
No abstract available in PubMed .
More Related Videos
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.1K
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
7.5K
